Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious post-viral condition that emerges following a COVID-19 infection. Recent clinical data suggests that MIS-C cardiovascular involvement serves as a primary driver of disease severity and patient prognosis. This study analyzed 54 pediatric patients to characterize the heart-related complications and their impact on long-term recovery.

Common Manifestations of Cardiac Injury

The research revealed that 37% of the children experienced significant cardiac issues. Specifically, mitral regurgitation occurred in half of these affected patients. Additionally, 20.4% demonstrated left ventricular dysfunction, while 18.5% presented with pericardial effusion. Notably, older children generally faced a higher risk of developing these complications compared to younger cohorts.

Predicting Severity in MIS-C Cardiovascular Involvement

Identifying high-risk patients early is crucial for effective management. Clinicians observed that tachycardia, hypotension, and tachypnea were frequent indicators of severe disease. Moreover, symptoms like dyspnea and chest pain strongly correlated with cardiac dysfunction. Consequently, these clinical markers help doctors stratify patients who might require more intensive monitoring or aggressive treatment protocols.

Recovery Trajectories and Outcomes

Most patients showed positive recovery trends during the follow-up period. However, the study utilized Kaplan-Meier and Cox regression analyses to determine that specific biomarker profiles influence recovery speed. Furthermore, early intervention appears to mitigate long-term sequelae. These findings emphasize the necessity of longitudinal cardiac follow-ups for all children diagnosed with MIS-C.

Frequently Asked Questions

What are the most frequent cardiac issues in children with MIS-C?

Mitral regurgitation is the most common finding, followed by left ventricular dysfunction and pericardial effusion. These conditions often require specialized pediatric cardiology support and serial echocardiography.

Which clinical symptoms suggest heart involvement in MIS-C?

Symptoms such as chest pain, dyspnea, tachycardia, and hypotension are key indicators. These signs often point toward a more severe clinical course and the immediate need for specialized cardiac imaging.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Saraç U et al. Cardiovascular Involvement and Its Association with Disease Severity and Recovery in SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Children. Vector Borne Zoonotic Dis. 2026 Jun 12. doi: 10.1177/15303667261457403. PMID: 42284067.

Alvarado-Gamarra G et al. Post-MIS-C Cardiovascular Outcomes: A Systematic Review. Eur J Pediatr. 2026 Feb 21. doi: 10.1007/s00431-026-06798-6.

MDPI. Cardiac Manifestations and Emerging Biomarkers in Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review and Meta-Analysis. 2025 May 19.